Immunogenicity of the DNA/Protein Combined Vaccine against COVID-19

During the COVID-19 pandemic, the development of prophylactic vaccines, including those based on new platforms, became highly relevant. One such platform is the creation of vaccines combining DNA and protein components in one construct. For the creation of DNA vaccine, we chose the full-length spike...

Descripción completa

Detalles Bibliográficos
Autores principales: Borgoyakova, M. B., Karpenko, L. I., Merkulyeva, I. A., Shcherbakov, D. N., Rudometov, A. P., Starostina, E. V., Shanshin, D. V., Isaeva, A. A., Nesmeyanova, V. S., Volkova, N. V., Belenkaya, S. V., Volosnikova, E. A., Zadorozhny, A. M., Orlova, L. A., Zaykovskaya, A. V., Pyankov, O. V., Bazhan, S. I., Ilyichev, A. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811049/
https://www.ncbi.nlm.nih.gov/pubmed/36598669
http://dx.doi.org/10.1007/s10517-023-05682-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811049/
https://www.ncbi.nlm.nih.gov/pubmed/36598669
http://dx.doi.org/10.1007/s10517-023-05682-9

Ejemplares similares